Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 6Recruiting 4Active not recruiting 1

Sponsor Class

OTHER_GOV 2OTHER 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1

Conditions

Smoldering Multiple Myeloma 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Hemangioma, Capillary 1Hemangioma 1Heart Failure 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Adrenergic beta-Antagonists × Clear all
NCT05312255 2025-12-01

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute

Phase NA Recruiting
175 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT06839144 2025-07-11

OC-POP-PT

Tel-Aviv Sourasky Medical Center

Phase 2 Recruiting
60 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

NCT01873131 2023-11-02

A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

Massachusetts General Hospital

Phase NA Recruiting
126 enrolled

Hemangioma, Hemangioma, Capillary

NCT02818517 2022-02-02

Evaluation and Management of Cardio Toxicity in Oncologic Patients

Tel-Aviv Sourasky Medical Center

Recruiting
1,000 enrolled

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡